AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

DANAZOL

7 registrations across 5 African markets— 5 active

Markets with DANAZOL

🇹🇳Tunisia
2 registrations
0 active
🇿🇦South Africa
2 registrations
2 active
🇲🇦Morocco
1 registration
1 active
🇳🇬Nigeria
1 registration
1 active
🇸🇳Senegal
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
Nazol Capsules
Capsule
🇳🇬NigeriaChez Resources Pharmaceutical LimitedactiveJan 2030
DANATROL
Gélule / 200 MG
🇹🇳TunisiaSANOFI-AVENTIS FRANCEexpiredJan 1988
DANATROL
Gélule / 200 MG
🇹🇳TunisiaSANOFI-AVENTIS FRANCEexpiredJan 1988
DANOGEN-200🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
DANOGEN-100🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
DANATROL
GELULE
🇲🇦Morocco—active—
DANATROL
gélule / 200 mg
🇸🇳SenegalSTERLING WINTHROPactive—

DANAZOL in Africa — Regulatory Overview

DANAZOL is registered across 5 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, South Africa, Morocco, Nigeria and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.